The authors of the report expand upon the traumatic and sociopolitical factors underlying presentations of psychosis and “schizophrenia.”
Street drug dealers and stimulant-peddling doctors both get clients high and addicted for profit. So there is really no difference between what they do except that doctors are more ‘successful’ at it, since they enjoy many advantages over illicit dealers and can get away with doing it legally.
In the wake of deinstitutionalization, we no longer have the vast asylum system we once did. Instead, something more insidious has taken root — for-profit institutions that call themselves neurorehabilitation centers, group homes, and other official-sounding names.
Childhood trauma victims have already been through far too much. Many find when they disclose abuse to GPs, the first thing that happens is a prescription for a benzodiazepine, which can lead to severely disabling adverse effects. How can this level of risk be justified for anyone, let alone vulnerable abuse survivors?
The time has come to halt the massive failure that has characterized schizophrenia molecular genetic research, and to thoroughly reassess what critics have always said are the severely flawed family, twin, and adoption studies that inspired and helped justify this research.
I believe that the greatest problem that we have with “psychosis,” voicehearing, and “schizophrenia” in the modern world is a simple lack of comprehension on the part of other people that what we experience is actually real, even if it might seem intractably bizarre from the outside.
Having smelled colors, heard ghosts, grown ecstatic, glimpsed Gaia, chatted with cartoons, and been overwhelmed by persistent paranoia and fear while under the influence of LSD, a modified fungus, I cannot distinguish how such plant-induced experiences differ from what psychiatrists call psychosis.
Drug Withdrawal Course
Mad in America Continuing Education is presenting a series of seven webinars on psychiatric drug withdrawal that will feature presentations by people with lived experience, psychiatrists and other professionals. Register here for the course, which begins on Oct. 24.
Lancet Psychiatry, a UK-based medical journal, recently published a study that concluded brain scans showed that individuals diagnosed with ADHD had smaller brains. That conclusion is belied by the study data. The journal needs to retract this study. UPDATE: Lancet Psychiatry (online) has published letters critical of the study, and the authors' response, and a correction.
Robert Whitaker Withdrawal Series
Sandy Steingard on Mad in America's Psychiatric Drug Withdrawal Course
Psychiatric Drug Withdrawal Course
Birgitta Alakare, MD at "Pharmaceuticals – Risks and Alternatives", 15th of October, 2016.
Sami Timimi, MD at "Pharmaceuticals – Risks and Alternatives", 15th of October, 2016.
Olga Runciman at "Pharmaceuticals – Risks and Alternatives," 15th of October, 2016
Open Paradigm Project - Will Eberle
Open Paradigm Project - Marty Hadge
"Moving Beyond Psychiatric Labels"
Carina Håkansson, PhD at "Pharmaceuticals – Risks and Alternatives", 15th of October, 2016.
John Read at "Pharmaceuticals – Risks and Alternatives," 15th of October, 2016.
Open Paradigm Project - Matt Samet
Open Paradigm Project - Sera Davidow
UCLA/ISEPP - Robert Whitaker
UCLA/ISEPP - Bob Fancher
Open Paradigm Project - Amy Long
Open Paradigm Project - Leah Harris
UCLA/ISEPP - Allen Frances
Open Paradigm Project - Cheryl Sharp
UCLA/ISEPP - Peter Whitehouse
UCLA/ISEPP - David Healy
Open Paradigm Project - Faith Rhyne
Antidepressants & Pregnancy: The risks and potential harm to normal fetal development
Open Paradigm Project - Leonard Roy Frank
Open Paradigm Project - Dorothy Dundas
UCLA/ISEPP - Bonnie Burstow
Open Paradigm Project - Sean Donovan
UCLA/ISEPP - John Read
Open Paradigm Project - Celia Brown
Open Paradigm Project - Joanna Moncrieff
Interview with Bruce Levine
Open Paradigm Project - Iden McCollum
Interview with Peter Gøtzsche
About Mad in America (2013)
Mad in America's International Film Festival
Will Hall at "Pharmaceuticals – Risks and Alternatives", 15th of October, 2016.
Open Paradigm Project - Jenna Fogle
Jaakko Seikkula, PhD at "Pharmaceuticals – Risks and Alternatives," 15th of October, 2016.
Open Paradigm Project - Laura Nicole Sisson
Open Paradigm Project - Oryx Cohen
Forced Psychiatric Detention